Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH05-08-0555
Issue:2006: 95/2 (Feb) pp. 205-395
Pages:221-223

Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation

Lucio Amitrano1 , Maria Anna Guardascione1 , Paul R. J. Ames 4 , Maurizio Margaglione3 , Luigi Iannaccone2 ,Vincenzo Brancaccio2 , Antonio Balzno
1 Gastroenterology and 2 Coagulation Units, A. Cardarelli Hospital, Naples, Italy; 3 Genetics Unit, University of Foggia, Foggia, Italy 4 Department of Hematology, Inverclyde Royal Hospital, Greenock, Scotland, UK

Summary

It was the aim of the present study to investigate factor II levelsin liver cirrhosis (LC) patients with portal vein thrombosis(PVT) carrying the heterozygous G20210A prothrombin (PT)mutation. Plasma concentrations of factor II,VII, X,V, protein C(PC) total protein S (tPS) antithrombin (AT) and D-dimers (DD)were measured in 13 LC patients with PVT heterozygous for PTG20210A, in 13 LC patients with PVT without PT G20210A and in 13 LC controls matched by age, sex and Child-Pugh score.Crude factor II and factor II/DD ratio were highest in LC patientswith PVT heterozygous for PT G20210A (p=0.03 andp=0.02 respectively).The factor II/PC ratio, expression of a procoagulant/anticoagulant imbalance was highest in the samegroup (p=0.0008). Plasma factor II levels are elevated in LCpatients heterozygous for PT G20210A and may favour PVT.

Keywords

liver cirrhosis, portal vein thrombosis, prothrombin

DOI

http://dx.doi.org/10.1160/TH05-08-0555

You may also be interested in...

1.

M. Caselitz, S. Wagner

Die Medizinische Welt 2008 59 6: 217-222

2.

Masahito Uemura1*, Yoshihiro Fujimura2*, Masanori Matsumoto2, Hiromichi Ishizashi2, Seiji Kato2, Tomomi Matsuyama1, Ayami Isonishi2, Masatoshi Ishikawa1, Masato Yagita4, Chie Morioka1, Hitoshi Yoshiji1, Tatsuhiro Tsujimoto1, Norio Kurumatani3, Hiroshi Fukui1

Thrombosis and Haemostasis 2008 99 6: 1019-1029

http://dx.doi.org/10.1160/TH08-01-0006

3.

Michael A. Bukys1, Tivadar Orban1, Paul Y. Kim2, Michael E. Nesheim2,3, Michael Kalafatis1,4

Thrombosis and Haemostasis 2008 99 3: 511-522

http://dx.doi.org/10.1160/TH07-08-0532



Articles

You've 435 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...